GSK scandal should prompt China to reflect on wider pharma corruption
As a new head of operations works out how best to guide GlaxoSmithKline’s China operation through a bribery scandal that has hit the world's headlines, industry watchers have have said the company is just the tip of the iceberg in a pharmaceutical...